Stock 688656 HOB BIOTECH GROUP CORP.,LTD
Add to a list
To use this feature you must be a member
Log inSign up

Financials HOB Biotech Group Corp.,Ltd

Equities

688656

CNE100004C37

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E.
Other stock markets
 03:30:00 03/06/2024 am IST 		5-day change 1st Jan Change
23.96 CNY -3.31% Intraday chart for HOB Biotech Group Corp.,Ltd -0.75% -31.07%
28/04 HOB Biotech Group Corp.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
11/03 HOB Biotech Group Corp.,Ltd announces an Equity Buyback for CNY 30 million worth of its shares. CI

Valuation

Fiscal Period: December 2021 2022 2023
Capitalization 1 3,973 2,114 2,192
Enterprise Value (EV) 1 3,549 1,890 2,084
P/E ratio 45 x 50.8 x 47 x
Yield 0.84% 0.89% 1.15%
Capitalization / Revenue 12.5 x 6.6 x 5.56 x
EV / Revenue 11.2 x 5.9 x 5.28 x
EV / EBITDA 34.2 x 27.4 x 24.1 x
EV / FCF -40.4 x -13.6 x -14.7 x
FCF Yield -2.47% -7.33% -6.79%
Price to Book 5.16 x 2.71 x 2.7 x
Nbr of stocks (in thousands) 63,058 63,058 63,058
Reference price 2 63.00 33.52 34.76
Announcement Date 24/04/22 25/04/23 25/04/24
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 201.4 259.1 221.9 317.7 320.4 394.4
EBITDA 1 59.44 84.04 65.48 103.9 68.95 86.55
EBIT 1 57.32 70.85 50.22 84.33 42.01 53.85
Operating Margin 28.45% 27.34% 22.64% 26.54% 13.11% 13.65%
Earnings before Tax (EBT) 1 46.71 73.56 65.1 99.13 46.48 56.63
Net income 1 40.15 63.84 56.62 86.19 41.65 47.33
Net margin 19.93% 24.64% 25.52% 27.13% 13% 12%
EPS 2 0.8800 1.350 1.200 1.400 0.6600 0.7400
Free Cash Flow 1 36.9 24.31 -59 -87.75 -138.6 -141.5
FCF margin 18.32% 9.38% -26.6% -27.62% -43.25% -35.89%
FCF Conversion (EBITDA) 62.08% 28.93% - - - -
FCF Conversion (Net income) 91.9% 38.09% - - - -
Dividend per Share - - 0.3000 0.5300 0.3000 0.4000
Announcement Date 19/04/19 23/12/20 14/04/21 24/04/22 25/04/23 25/04/24
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 47.5 40.7 14.8 424 224 108
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 36.9 24.3 -59 -87.8 -139 -142
ROE (net income / shareholders' equity) 37.9% 45.2% 31.8% 17.7% 5.38% 5.95%
ROA (Net income/ Total Assets) 19.4% 17.4% 10.8% 9.09% 2.9% 3.55%
Assets 1 207.1 366.5 522.7 948.7 1,435 1,332
Book Value Per Share 2 2.810 3.160 4.360 12.20 12.40 12.90
Cash Flow per Share 2 1.410 1.920 1.240 7.130 2.440 2.590
Capex 1 26.7 34.8 57 168 220 178
Capex / Sales 13.23% 13.43% 25.7% 52.84% 68.73% 45.14%
Announcement Date 19/04/19 23/12/20 14/04/21 24/04/22 25/04/23 25/04/24
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
HOB BIOTECH GROUP CORP.,LTD Stock HOB Biotech Group Corp.,Ltd
-31.07% 21Cr
ABBOTT LABORATORIES Stock Abbott Laboratories
-6.60% 18TCr
MEDTRONIC PLC Stock Medtronic plc
-1.01% 11TCr
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-2.50% 6.7TCr
DEXCOM, INC. Stock DexCom, Inc.
-6.57% 4.72TCr
CENCORA, INC. Stock Cencora, Inc.
+11.34% 4.46TCr
HOYA CORPORATION Stock Hoya Corporation
+9.25% 4.25TCr
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+14.66% 3TCr
TERUMO CORPORATION Stock Terumo Corporation
+15.97% 2.52TCr
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
-6.43% 2.41TCr
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. 688656 Stock
  4. Financials HOB Biotech Group Corp.,Ltd